发明名称 System for optimizing a drug dosage regimen over time
摘要 A system for optimizing a patient's basal insulin dosage regimen over time, adapted to determine from blood glucose values whether and by how much to vary a patient's present recommended amount of the insulin-containing drug in order to maintain the patient's future blood glucose level measurements within a predefined range, and wherein a given blood glucose value is disregarded if no patient-actuated operation being indicative of the administration of a dose of an insulin containing drug has been detected in a pre-defined amount of time prior to the determination of the given blood glucose value.
申请公布号 US9636461(B2) 申请公布日期 2017.05.02
申请号 US201214115799 申请日期 2012.05.02
申请人 Novo Nordisk A/S 发明人 Bengtsson Henrik;Christensen Toke Folke
分类号 A61M5/24;G06F19/00;A61B5/145;A61M5/315;A61M5/32;G06Q50/22;A61M5/31 主分类号 A61M5/24
代理机构 代理人 Lum Leon Y.
主权项 1. A system for optimizing a patient's basal insulin dosage regimen over time, comprising: a blood glucose meter for receiving a patient blood sample and generating a blood glucose data set corresponding to a blood glucose value of the patient blood sample, detecting means that detect when a patient-actuated operation is performed, the operation being indicative of an administration of a dose of an insulin containing drug, memory means that to store: blood glucose data sets corresponding to a plurality of blood glucose values as a function of time, data representing detected patient-actuated operations as a function of time, and data representing an initial basal insulin dosage regimen, a processor operatively connected to the memory means, the processor being programmed to determine, based on blood glucose data sets determined at a plurality of times, whether and by how much to vary a component in a present insulin dosage regimen in order to maintain future blood-glucose-level measurements within a predefined range, and output means that communicate to the patient a component in the patient's insulin dosage regimen, wherein the processor is programmed to disregard a given blood glucose data set if no patient-actuated operation has been detected in a pre-defined amount of time prior to generating the given data set.
地址 Bagsvaerd DK
您可能感兴趣的专利